Should intravesical Bacillus Calmette–Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?

• Hyeong Dong Yuk,

  Roles Data curation, Formal analysis, Investigation, Software, Writing – original draft

  Affiliation Department of Urology, Inje University Sanggye Paik Hospital, Seoul, Korea

  ⨯
• Chang Wook Jeong,

  Roles Conceptualization

  Affiliation Department of Urology, Seoul National University Hospital, Seoul, Korea

  ⨯
• Cheol Kwak,

  Roles Conceptualization, Methodology, Supervision

  Affiliation Department of Urology, Seoul National University Hospital, Seoul, Korea

  http://orcid.org/0000-0002-1987-2111

  ⨯
• Hyeon Hoe Kim,

  Roles Formal analysis, Investigation, Methodology

  Affiliation Department of Urology, Seoul National University Hospital, Seoul, Korea

  ⨯
• Ja Hyeon Ku

  Roles Conceptualization, Formal analysis, Funding acquisition, Supervision, Writing – review & editing

  * E-mail: kuuro70@snu.ac.kr

  Affiliation Department of Urology, Seoul National University Hospital, Seoul, Korea

  http://orcid.org/0000-0002-0391-2342

  ⨯